Human mast cell activation by Staphylococcus aureus: Interleukin-8 and tumor necrosis factor alpha release and the role of toll-like receptor 2 and CD48 molecules

Infection and Immunity

Volumn 76, Issue 10, 2008, Pages 4489-4497

  Rocha de Souza, Claudio M ^a   Berent Maoz, Beata ^a   Mankuta, David ^b   Moses, Allon E ^b   Levi Schaffer, Francesca ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD48 ANTIGEN; CYTOCHALASIN D; INTERLEUKIN 8; RECEPTOR ANTIBODY; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CYTOKINE RELEASE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INFLAMMATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UMBILICAL CORD BLOOD;

ANTIGENS, CD; BACTERIAL ADHESION; CELLS, CULTURED; CYTOPLASM; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-8; MAST CELLS; MICROBIAL VIABILITY; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 53649083007     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00270-08     Document Type: Article

References (48)

1. Agerer, F., S. Waeckerle, and C. R. Hauck. 2004. Microscopic quantification of bacterial invasion by a novel antibody-independent staining method. J. Microbiol. Methods. 59:23-32.
2. Arock, M., E. Ross, R. Lai-Kuen, G. Averlant, Z. Gao, and S. N. Abraham. 1998. Phagocytic and tumor necrosis factor alpha response of human mast cells following exposure to gram-negative and gram-positive bacteria. Infect. Immun. 66:6030-6043.
3. Bachelet, I., A. Munitz, D. Mankuta, and F. Levi-Schaffer. 2006. Mast cell costimulation by CD226/CD112 (DNAM-1/Nectin-2): a novel interface in the allergic process. J. Biol. Chem. 281:27190-27196.
4. Bachert, C., N. Zang, J. Patou, T. Van Zele, and P. Gevaert. 2008. Role of staphylococcal superrantigens in upper airway disease. Curr. Opin. Allergy. Clin. Immunol. 8:34-38.
5. Baker, B. S. 2006. The role of microorganisms in atopic dermatitis. Clin. Exp. Immunol. 144:1-9.
6. Burns, E., G. Bachrach, L. Shapira, and G. Nussbaum. 2006. Cutting edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J. Immunol. 177:8296-8300.
7. Conley, D. B., A. Tripathi, A. M. Ditto, K. Reid, L. C. Grammer, and R. C. Kern. 2004. Chronic sinusitis with nasal polyps: staphylococcal exotoxin immunoglobulin E and cellular inflammation. Am. J. Rhinol. 18:273-278.
8. Dziarski, R., and D. Gupta. 2005. Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect. Immun. 73:5212-5216.
9. Féger, F., S. Varadaradjalou, Z. Gao, S. N. Abraham, and M. Arock. 2002. The role of mast cells in host defense and their subversion by bacterial pathogens. Trends. Immunol. 23:151-158.
10. Feng, B. S., S. H. He, P. Y. Zheng, L. Wu, and P. C. Yang. 2007. Mast cells play a crucial role in Staphylococcus aureus peptidoglycan-induced diarrhea. Am. J. Pathol. 171:537-547.
11. Fournier, B., and D. J. Philpott. 2005. Recognition of Staphylococcus aureus by the innate immune system. Clin. Microbiol. Rev. 18:521-540.
12. Gould, H. J., P. Takhar, H. E. Harries, E. Chevretton, and B. J. Sutton. 2007. The allergic march from Staphylococcus aureus superantigens to immunoglobulin E. Chem. Immunol. Allergy. 93:106-136.
13. Greiner, W., A. Rasch, D. Kohler, B. Salzberger, G. Fatkenheuer, and M. Leidig. 2007. Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients. Clin. Microbiol. Infect. 13:264-268.
14. Jung, K. Y., J. D. Cha, S. H. Lee, W. H. Woo, D. S. Lim, B. K. Choi, and K. J. Kim. 2001. Involvement of staphylococcal protein A and cytoskeletal actin in Staphylococcus aureus invasion of cultured human oral epithelial cells. J. Med. Microbiol. 50:35-41.
15. Kintarak, S., S. A. Whawell, P. M. Speight, S. Packer, and S. P. Nair. 2004. Internalization of Staphylococcus aureus by human keratinocytes. Infect. Immun. 72:5668-5676.
16. Kubica, M., K. Guzik, J. Koziel, M. Zarebski, W. Richter, B. Gajkowska, A. Golda, A. Maciag-Gudowska, K. Brix, L. Shaw, T. Foster, and J. Potempa. 2008. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS ONE 3:1-16.
17. Lin, T. J., R. Garduno, R. T. Boudreau, and A. C. Issekutz. 2002. Pseudomonas aeruginosa activates human mast cells to induce neutrophil transendothelial migration via mast cell-derived IL-1 alpha and beta. J. Immunol. 169:4522-4530.
18. Lin, T. J., Z. Gao, M. Arock, and S. N. Abraham. 1999. Internalization of FimH+ Escherichia coli by the human mast cell line (HMC-1 5C6) involves protein kinase C. J. Leukoc. Biol. 66:1031-1038.
19. Malaviya, R., E. A. Ross, J. I. MacGregor, T. Ikeda, J. R. Little, B. A. Jakschik, and S. N. Abraham. 1994. Mast cell phagocytosis of FimH-expressing enterobacteria. J. Immunol. 152:1907-1914.
20. Malaviya, R., and S. N. Abraham. 2001. Mast cell modulation of immune responses to bacteria. Immunol. Rev. 179:16-24.
21. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381:77-80.
22. Malaviya, R., Z. Gao, K. Thankavel, P. A. van der Merwe, and S. N. Abraham. 1999. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc. Natl. Acad. Sci. USA 96:8110-8115.
23. Massey, R. C., M. N. Kantzanou, T. Fowler, N. P. Day, K. Schofield, E. R. Wann, A. R. Berendt, M. Hook, and S. J. Peacock. 2001. Fibronectin-binding protein A of Staphylococcus aureus has multiple, substituting, binding regions that mediate adherence to fibronectin and invasion of endothelial cells. Cell. Microbiol. 3:839-851.
24. Matsui, K., and A. Nishikawa. 2006. Percutaneous application of peptidoglycan from Staphylococcus aureus induces mast cell development in mouse spleen. Int. Arch. Allergy Immunol. 139:271-278.
25. Matsui, K., M. Wirotessangthong, and A. Nishikawa. 2007. Percutaneous application of peptidoglycan from Staphylococcus aureus induces eosinophil infiltration in mouse skin. Clin. Exp. Allergy 37:615-622.
26. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397.
27. Mempel, M., C. Schnopp, M. Hojka, H. Fesq, S. Sweidinger, M. Schaller, H. C. Korting, J. Ring, and D. Abeck. 2002. Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin-independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death. Br. J. Dermatol. 146:943-951.
28. Mielcarek, N., E. H. Hornquist, B. R. Johansson, C. Locht, S. N. Abraham, and J. Holmgren. 2001. Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin. Cell. Microbiol. 3:181-188.
29. Munitz, A., I. Bachelet, F. D. Finkelman, M. E. Rothenberg, and F. Levi-Schaffer. 2007. CD48 is critically involved in allergic eosinophilic airway inflammation. Am. J. Respir. Crit. Care. Med. 175:911-918.
30. Munitz, A., I. Bachelet, R. Eliashar, M. Khodoun, F. D. Finkelman, M. E. Rothenberg, and F. Levi-Schaffer. 2006. CD48 is an allergen and IL-3-induced activation molecule on eosinophils. J. Immunol. 177:77-83.
31. Muñoz, S., R. Hernandez-Pando, S. N. Abraham, and J. A. Enciso. 2003. Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J. Immunol. 170:5590-5596.
32. Pils, S., T. Schmitter, F. Neske, and C. R. Hauck. 2006. Quantification of bacterial invasion into adherent cells by flow cytometry. J. Microbiol. Methods 65:301-310.
33. Regueiro, V., M. A. Campos, J. Pons, S. Alberti, and J. A. Bengoechea. 2006. The uptake of a Klebsiella pneumoniae capsule polysaccharide mutant triggers an inflammatory response by human airway epithelial cells. Microbiology 152:555-566.
34. Rocha-De-Souza, C. M., A. L. Mattos-Guaraldi, R. Hirata, Jr., L. O. Moreira, L. H. Monteiro-Leal, A. C. Freitas-Almeida, L. Mendonca-Previato, J. O. Previato, and A. F. Andrade. 2003. Influence of polarisation and differentiation on interaction of 43-kDa outer-membrane protein of Aeromonas caviae with human enterocyte-like Caco-2 cell line. Int. J. Mol. Med. 11:661-667.
35. Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95:588-593.
36. Schröder, A., R. Kland, A. Peschel, C. Von Eiff, and M. Aepfelbacher. 2006. Live cell imaging of phagosome maturation in Staphylococcus aureus infected human endothelial cells: small colony variants are able to survive in lysosomes. Med. Microbiol. Immunol. 195:185-194.
37. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274:17406-17409.
38. Seiberling, K. A., D. B. Conley, A. Tripathi, L. C. Grammer, L. Shuh, G. K. Haines III, R. Schleimer, and R. C. Kern. 2005. Superantigens and chronic rhinosinusitis: detection of staphylococcal exotoxins in nasal polyps. Laryngoscope 115:1580-1585.
39. Shin, J. S., and S. N. Abraham. 2001. Glycosylphosphatidylinositol-anchored receptor-mediated bacterial endocytosis. FEMS. Microbiol. Lett. 197:131-138.
40. Supajatura, V., H. Ushio, A. Nakao, S. Akira, K. Okumura, C. Ra, and H. Ogawa. 2002. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Investig. 109:1351-1359.
41. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392-5396.
42. Varadaradjalou, S., F. Féger, N. Thieblemont, N. B. Hamouda, J. M. Pleau, M. Dy, and M. Arock. 2003. Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4) differentially activate human mast cells. Eur. J. Immunol. 33:899-906.
43. Veltrop, M. H., J. Thompson, and H. Beekhuizen. 2001. Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells. Infect. Immun. 69:2797-2807.
44. Voyich, J. M., K. R. Braughton, D. E. Sturdevant, A. R. Whitney, B. Said-Salim, S. F. Porcella, R. D. Long, D. W. Dorward, D. J. Gardner, B. N. Kreiswirth, G. M. Musser, and F. R. DeLeo. 2005. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 175:3907-3919.
45. Wang, T., W. P. Lafuse, and B. S. Zwilling. 2000. Regulation of toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J. Immunol. 165:6308-6313.
46. Watanabe, I., M. Ichiki, A. Shiratsuchi, and Y. Nakanishi. 2007. TLR2-mediated survival of Staphylococcus aureus in macrophages: a novel bacterial strategy against host innate immunity. J. Immunol. 178:4917-4925.
47. Yumoto, H., H. H. Chou, Y. Takahashi, M. Davey, F. C. Gibson III, and C. A. Genco. 2005. Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of Toll-like receptor 4 by bacterial fimbria-dependent invasion. Infect. Immun. 73:8050-8059.
48. Zhang, Q., N. Mousdicas, Q. Yi, Al-Hassani, S. D. Billings, S. M. Perkins, K. M. Howard, S. Shii, T. Shimizu, and J. B. Travers. 2005. Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. J. Clin. Investig. 115:2855-2861.